Grahame Bulfield | |
---|---|
Citizenship | British |
Alma mater | University of Leeds |
Known for | Former Director of the Roslin Institute, Edinburgh |
Awards | CBE, FRSE, HonFRS |
Scientific career | |
Fields | Animal Genetics |
Institutions | University of Edinburgh |
Thesis | Genetical and biochemical studies of fatness in mice |
Doctoral advisor | C.H. Waddington, D.S. Falconer, H. Kacser, G.S. Boyd |
Grahame Bulfield, CBE, FRSE, Hon FRASE (born 1941) is an English geneticist, vice-principal and Emeritus Professor of Genetics at the University of Edinburgh. He is best known as the former director and chief executive of the Roslin Institute, Edinburgh, when in 1996 the research group led by Ian Wilmut first cloned a mammal from an adult somatic cell, a Finnish Dorset lamb named Dolly. [1] [2] [3]
Grahame Bulfield was born in 1941 in Leeds, was educated in Cheshire, where his interest in agriculture and farming started to grow. In 1959 he enrolled at the University of Leeds, reading for a BSc in Agriculture with Honours in animal production. His curiosity for genetics fully blossomed and he took to completion his honours project on the subject of "Beef Sire Performance and Progeny Test". [4] Upon recommendation by a lecturer, with the support of a scholarship from the Ministry of Agriculture, in 1964 he enlisted the Institute of Animal Genetics in Edinburgh, studying for a Diploma in Animal Genetics. Having gained valuable international experience in Sweden, at the University of Uppsala, as a Travelling Fellow of the Yorkshire Agricultural Society, he registered for a PhD in Genetics at the University of Edinburgh, with a studentship from the Agricultural Research Council. [4] His specific area of interest was the biochemical genetics of two obese mutants in the mouse, and under the supervision of C.H. Waddington, D.S. Falconer, Henrik Kacser and G.S. Boyd, he presented his thesis "Genetical and biochemical studies of fatness in mice". [5] After his PhD and until 1971 he was involved in the Department of Genetics with the University of California, as a Fulbright Fellow. [4]
In 1971, once returned to Edinburgh, he worked with Henrik Kacser on two projects funded by the MRC, concerning the screening and analysis of mouse mutants of human inherited disease. [4] In 1976 he was selected as a Lecturer and Medical Convenor of Medical Genetics at the University of Leicester. [6] Here his research extended from mouse disease mutants to the genetic control of gene expression, and the genetics of growth. [4] His studies led him to discover of a mutation on the mouse X-chromosome, responsible to cause the Duchenne and the Becker muscular dystrophy in humans, and thus opening a path to a possible cure. [7] He was appointed head of the Genetics Group at the Poultry Research Centre of Edinburgh in 1981, a part of which merged into the Institute of Animal Physiology and Genetics Research (IAPGR), having its own newly built Edinburgh Research Station in 1986. He was nominated head of the Gene Expression Group, becoming head of the whole station in 1988. Subsequently, this renamed itself Roslin Institute, as an independent body from its sister institute in Cambridge, and Bulfield was elected as its chief executive and director. [4] At Roslin he spearheaded pioneering projects with cutting-edge technology that made selective breeding of livestock animals easier, carrying on a tradition thousands of years old. His research covered the wide spectrum of genetics and molecular biology, analysing genetic similarities that exist between humans and other species. Production of animal feedstuff, cereals, milk, meat, benefited all from the findings of his research. Not only that, but this increased in-depth knowledge in the genetic sciences eased the way to curing and preventing human diseases and to the development of the new industry of bio-farming. [8] In 1996 the cloning of Dolly the sheep at Roslin received wide attention both in the public domain and in the scientific arena, raising questions and debates on the ethical aspects and implications of it. He sustained that science can be used for good or evil, and that his job as a scientist was to put as much information out in the public domain, so that the public and government could judge it. [9] Once Pasteur started to apply science to medicine in 1850, he let the genie out of the bottle. [10] He argued that the knowledge itself must be seen in a social context and that if Roslin had not gone ahead with Dolly, somebody else would have done it anyway. [9] If Dolly represented the living proof that animals could help humanity by producing organs and medicines, many saw her arrival as the prelude to human cloning. However, facing a worldwide diffused moral panic, he argued that he would be absolutely flabbergasted if we saw it happening in his lifetime, and that it was a nonsensical bit of hype. [11] Nevertheless, in 1997, he and his team at Roslin in charge of the Dolly's project, led by Ian Wilmut, had to appear before the House of Commons Select Committee on Science and Technology to answer questions on cloning. [4] As a result, the UK's Ministry of Agriculture cut off funding to the project, just when the team was celebrating the publication of their work in the journal Nature. He was shocked and stated that he would move heaven and Earth to keep resources in that cloning program. Their effort to perfect transgenic animal that could well improve farming conditions was under threat by the effect of cuts, resulting in more redundancies in permanent staff. [12] In response the Institute raised £6M in commercial funding to exploit the cloning technology and established a company Roslin BioMed to take this forward; this was later sold to the Californian Company Geron. When in 2001 Roslin entered a partnership with Viragen (Amex) to exploit the institute's transgenic chicken technology, he stated as its CEO that both he and his colleagues at Roslin believed to have found the ideal partner in Viragen and were looking forward to an extremely productive collaboration. [13] Since then he has served in an advisory capacity to several government and public committees, and as a consultant to a UK biotechnology company. [4]
In 1990 he was nominated Honorary Professor of the University of Edinburgh, and subsequently to a Personal Chair of Animal Genetics in 2002. [4] He was elected as Fellow of the Royal Society of Edinburgh in 1992. [14] In 1999 he was appointed Honorary Fellow of the Royal Agricultural Society of England. He was awarded a CBE for services to Animal Genetics in 2001. He is currently Emeritus Professor of Genetics at the University of Edinburgh. [4]
Cloning is the process of producing individual organisms with identical genomes, either by natural or artificial means. In nature, some organisms produce clones through asexual reproduction; this reproduction of an organism by itself without a mate is known as parthenogenesis. In the field of biotechnology, cloning is the process of creating cloned organisms of cells and of DNA fragments.
Dolly was a female Finn-Dorset sheep and the first mammal that was cloned from an adult somatic cell. She was cloned by associates of the Roslin Institute in Scotland, using the process of nuclear transfer from a cell taken from a mammary gland. Her cloning proved that a cloned organism could be produced from a mature cell from a specific body part. Contrary to popular belief, she was not the first animal to be cloned.
Anthony John Clark OBE FRSE was an English molecular biologist who was a founder of applying molecular technology to farm animals. He was director of the Roslin Institute from 2002 to 2004.
Sir Ian Wilmut was a British embryologist and the chair of the Scottish Centre for Regenerative Medicine at the University of Edinburgh. He is best known as the leader of the research group that in 1996 first cloned a mammal from an adult somatic cell, a Finnish Dorset lamb named Dolly.
Polly and Molly, two ewes, were the first mammals to have been successfully cloned from an adult somatic cell and to be transgenic animals at the same time. This is not to be confused with Dolly the Sheep, the first animal to be successfully cloned from an adult somatic cell where there wasn’t modification carried out on the adult donor nucleus. Polly and Molly, like Dolly the Sheep, were cloned at the Roslin Institute in Edinburgh, Scotland.
A biologist is a scientist who conducts research in biology. Biologists are interested in studying life on Earth, whether it is an individual cell, a multicellular organism, or a community of interacting populations. They usually specialize in a particular branch of biology and have a specific research focus.
Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer, epigenetic reprogramming and neurological diseases.
This page provides an alphabetical list of articles and other pages about biotechnology.
Megan and Morag, two domestic sheep, were the first mammals to have been successfully cloned from differentiated cells. They are not to be confused with Dolly the sheep which was the first animal to be successfully cloned from an adult somatic cell or Polly the sheep which was the first cloned and transgenic animal. Megan and Morag, like Dolly and Polly, were cloned at the Roslin Institute in Edinburgh, Scotland in 1995.
Ralph Lawrence Brinster is an American geneticist, National Medal of Science laureate, and Richard King Mellon Professor of Reproductive Physiology at the School of Veterinary Medicine, University of Pennsylvania.
Keith Henry Stockman Campbell was a British biologist who was a member of the team at Roslin Institute that in 1996 first cloned a mammal, a Finnish Dorset lamb named Dolly, from fully differentiated adult mammary cells. He was Professor of Animal Development at the University of Nottingham. In 2008, he received the Shaw Prize for Medicine and Life Sciences jointly with Ian Wilmut and Shinya Yamanaka for "their works on the cell differentiation in mammals".
Genetically modified animals are animals that have been genetically modified for a variety of purposes including producing drugs, enhancing yields, increasing resistance to disease, etc. The vast majority of genetically modified animals are at the research stage while the number close to entering the market remains small.
Genetically modified mammals are mammals that have been genetically engineered. They are an important category of genetically modified organisms. The majority of research involving genetically modified mammals involves mice with attempts to produce knockout animals in other mammalian species limited by the inability to derive and stably culture embryonic stem cells.
Genetic engineering is the science of manipulating genetic material of an organism. The first artificial genetic modification accomplished using biotechnology was transgenesis, the process of transferring genes from one organism to another, first accomplished by Herbert Boyer and Stanley Cohen in 1973. It was the result of a series of advancements in techniques that allowed the direct modification of the genome. Important advances included the discovery of restriction enzymes and DNA ligases, the ability to design plasmids and technologies like polymerase chain reaction and sequencing. Transformation of the DNA into a host organism was accomplished with the invention of biolistics, Agrobacterium-mediated recombination and microinjection. The first genetically modified animal was a mouse created in 1974 by Rudolf Jaenisch. In 1976 the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. In 1983 an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value.
The Roslin Institute is an animal sciences research institute at Easter Bush, Midlothian, Scotland, part of the University of Edinburgh, and is funded by the Biotechnology and Biological Sciences Research Council.
Tracy was a transgenically modified sheep created by scientists at Scotland's Roslin Institute to produce the human protein alpha 1-antitrypsin, a substance regarded in the 1990s as a potential pharmaceutical for the treatments of cystic fibrosis and emphysema. Notably, she is the first transgenic farm mammal ever created.
In re Roslin Institute (Edinburgh), 750 F.3d 1333 (Fed. Cir. 2014), is a 2014 decision of the United States Court of Appeals for the Federal Circuit rejecting a patent for a cloned sheep known as "Dolly the Sheep"— the first mammal ever cloned from an adult somatic cell.
Aspects of genetics including mutation, hybridisation, cloning, genetic engineering, and eugenics have appeared in fiction since the 19th century.
Hugh Paterson Donald (1908–1989) was a New Zealand-born, British biologist, noteworthy as an important contributor to Peter Medawar's research on skin grafts.
{{cite journal}}
: Cite journal requires |journal=
(help)